Hormonal
GLP-1 receptor agonists (specifically semaglutide and liraglutide) and dual GIP/GLP-1 agonists (tirzepatide) produce significant, dose-dependent weight loss in patients with type 2 diabetes, making them superior to weight-gain-promoting medications like insulin and sulfonylureas for weight-centric management.
If you have Type 2 Diabetes and struggle with weight, ask your doctor about GLP-1 agonists (like semaglutide) or dual agonists (like tirzepatide). These drugs not only control blood sugar but also promote significant weight loss (up to 15-20% in trials) by slowing digestion and reducing appetite, unlike older drugs like insulin which often cause weight gain.
GLP-1 agonists (i.e., liraglutide and semaglutide) are the only anti-diabetic medications to be FDA approved for weight loss as well... Weekly subcutaneous of 2.4 mg semaglutide injections resulted in 15.8% of total body weight loss percentage (TBWL%) compared to 6.4% with daily injections of liraglutide 3.0 mg... Tirzepatide 15 mg was 20.9% (p < 0.001 for all comparisons with placebo)
Why this rating
Based on multiple systematic reviews, meta-analyses, and randomized clinical trials (RCTs) cited in the text.
Source
Weight-centric treatment of type 2 diabetes mellitus
Wissam Ghusn et al. · Obesity Pillars · 2022
DOI 10.1016/j.obpill.2022.100045
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →